Scarica l'app Stockscreener
4.46
3.67%
-0.17
Dopo l'orario di chiusura:
4.37
-0.09
-2.02%
Precedente Chiudi:
$4.63
Aprire:
$4.61
Volume 24 ore:
533.74K
Relative Volume:
0.63
Capitalizzazione di mercato:
$501.75M
Reddito:
$69.56M
Utile/perdita netta:
$-240.05M
Rapporto P/E:
-1.5119
EPS:
-2.95
Flusso di cassa netto:
$-121.90M
1 W Prestazione:
+9.05%
1M Prestazione:
+11.50%
6M Prestazione:
+211.89%
1 anno Prestazione:
+58.16%
Intervallo 1D:
$4.35
$4.67
Intervallo di 1 settimana:
$4.17
$4.80
Portata 52W:
$1.05
$4.80
Adc Therapeutics Sa Stock (ADCT) Company Profile
Nome
Adc Therapeutics Sa
Settore
Industria
Telefono
41 21 653 02 00
Indirizzo
BIOPOLE, EPALINGES
Confronta ADCT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADCT
Adc Therapeutics Sa
|
4.46 | 520.87M | 69.56M | -240.05M | -121.90M | -2.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Adc Therapeutics Sa Stock (ADCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-08 | Iniziato | Stephens | Overweight |
| 2024-05-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-03-28 | Iniziato | Guggenheim | Buy |
| 2023-08-10 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2023-04-24 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-12-06 | Iniziato | CapitalOne | Overweight |
| 2022-11-09 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-09-21 | Iniziato | JP Morgan | Overweight |
| 2022-09-09 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-09 | Iniziato | Wolfe Research | Outperform |
| 2021-08-17 | Ripresa | Jefferies | Buy |
| 2021-08-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-06-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-12-03 | Iniziato | Stifel | Hold |
| 2020-10-29 | Iniziato | H.C. Wainwright | Buy |
| 2020-06-09 | Iniziato | BofA/Merrill | Buy |
| 2020-06-09 | Iniziato | Cowen | Outperform |
Mostra tutto
Adc Therapeutics Sa Borsa (ADCT) Ultime notizie
Momentum divergence signals in ADC Therapeutics SA chart2025 Market Overview & Growth Focused Investment Plans - newser.com
Using AI based signals to follow ADC Therapeutics SAMarket Performance Summary & Consistent Growth Stock Picks - newser.com
Is ADC Therapeutics SA Common Shares stock trading at attractive multiplesInsider Buying & AI Enhanced Trade Execution Alerts - newser.com
How institutional ownership impacts ADC Therapeutics SA stock2025 Short Interest & Long-Term Safe Investment Plans - newser.com
ADC Therapeutics SA Hits New 52-Week High of $4.80 - Markets Mojo
Why retail traders accumulate ADC Therapeutics SA Common Shares stockWeekly Stock Recap & Weekly High Return Forecasts - newser.com
ADC Therapeutics SA (ADCT) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
What indicators show strength in ADC Therapeutics SAQuarterly Market Summary & Stepwise Swing Trade Plans - newser.com
Why analysts upgrade ADC Therapeutics SA stock2025 Year in Review & Proven Capital Preservation Tips - newser.com
Will ADC Therapeutics SA Common Shares stock boost dividends furtherJuly 2025 News Drivers & Entry and Exit Point Strategies - newser.com
What earnings revisions data tells us about ADC Therapeutics SA2025 EndofYear Setup & Trade Opportunity Analysis - newser.com
ADC Therapeutics SA stock outlook for YEARJuly 2025 Rallies & Low Drawdown Investment Strategies - newser.com
Published on: 2025-11-01 01:08:52 - newser.com
Is ADC Therapeutics SA stock a top pick in earnings seasonWeekly Stock Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
What insider trading reveals about ADC Therapeutics SA stock2025 Stock Rankings & Community Trade Idea Sharing Platform - newser.com
Will ADC Therapeutics SA Common Shares stock beat Nasdaq index returns2025 Performance Recap & High Conviction Investment Ideas - newser.com
ADC Therapeutics (NYSE:ADCT) Reaches New 1-Year HighTime to Buy? - MarketBeat
Is ADC Therapeutics SA stock dividend yield sustainableQuarterly Market Summary & Reliable Breakout Forecasts - newser.com
ADC Therapeutics SA (NYSE:ADCT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
How to track smart money flows in ADC Therapeutics SA2025 Investor Takeaways & Target Return Focused Picks - newser.com
ADC Therapeutics (ADCT) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Is ADC Therapeutics SA stock bottoming outJuly 2025 Earnings & Expert Verified Movement Alerts - newser.com
Is ADC Therapeutics SA showing signs of accumulationPortfolio Risk Report & Weekly Consistent Profit Watchlists - newser.com
Is it time to cut losses on ADC Therapeutics SAWeekly Trend Recap & Fast Entry Momentum Alerts - newser.com
Is ADC Therapeutics SA stock cheap compared to fundamentalsWeekly Trade Report & Weekly High Potential Stock Alerts - newser.com
Visual analytics tools that track ADC Therapeutics SA performance2025 Short Interest & Community Trade Idea Sharing - newser.com
Is ADC Therapeutics SA stock a buy on dips2025 Trading Recap & Precise Trade Entry Recommendations - newser.com
Will ADC Therapeutics SA Common Shares stock draw ESG focused funds2025 Earnings Surprises & Verified High Yield Trade Plans - newser.com
Is ADC Therapeutics SA stock attractive for long term wealth buildingBull Run & Consistent Return Strategy Ideas - newser.com
Adc Therapeutics Sa Azioni (ADCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):